Page last updated: 2024-11-02

piracetam and Cyanosis

piracetam has been researched along with Cyanosis in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hamed, SA1
Elhadad, AF1
Farghaly, HS1
Maury, P1
Sacher, F1
Rollin, A1
Duparc, A1
Mondoly, P1
Probst, V1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effectiveness of Valproic Acid in Treating Frequent Cyanotic Breath Holding Spells[NCT04482764]Phase 1150 participants (Actual)Interventional2017-01-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for piracetam and Cyanosis

ArticleYear
Evaluation of the effectiveness of valproic acid for treating cyanotic breath holding spells: A Pilot prospective study.
    Expert review of clinical pharmacology, 2020, Volume: 13, Issue:11

    Topics: Affect; Anticonvulsants; Breath Holding; Child, Preschool; Cyanosis; Electroencephalography; Female;

2020
Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2012, Volume: 14, Issue:1

    Topics: Adolescent; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cyanosis; Defibrillators, Implanta

2012